Product Information
BISACODYL EC 5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0441 per EA under NDC 00904674817. Its NADAC has been published 390 times since Apr 17, 2019.
Strength
5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904674817
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISACODYLApproval Type
OTC MONOGRAPH DRUG
FDA Application
505G(a)(3)On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for BISACODYL EC 5 MG TABLET has been published 390 times since Apr 17, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0441 per EA |
|---|---|
| All-time high | $0.0575 (Jun 16, 2021) |
| All-time low | $0.0315 (Jul 21, 2021) |
| 52-week high | $0.0464 |
| 52-week low | $0.0350 |
| Median price | $0.0385 |
| Average price | $0.0401 |
| Largest weekly change | +41.1% (Jan 18, 2023) |
| Weeks tracked | 390 |
| Tracking since | Apr 17, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisacodyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Stimulant Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BISACODYL EC 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BISACODYL EC 5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0441 per EA (NDC 00904674817), effective Sep 30, 2026.
How has the price of BISACODYL EC 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BISACODYL EC 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 390 weekly CMS publications since Apr 17, 2019.
What are the highest and lowest recorded NADAC prices for BISACODYL EC 5 MG TABLET?
Since Apr 17, 2019, the NADAC for BISACODYL EC 5 MG TABLET has ranged from a low of $0.0315 (Jul 21, 2021) to a high of $0.0575 (Jun 16, 2021), with a median of $0.0385 per EA.
Are there cheaper alternatives to BISACODYL EC 5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM LAXATIVE EC 5 MG TABLET, is $0.0372 per EA — about 16% below BISACODYL EC 5 MG TABLET.
Who manufactures BISACODYL EC 5 MG TABLET?
BISACODYL EC 5 MG TABLET (NDC 00904674817) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.